secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001140361-24-040514
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys receives FDA 510(k) clearance for FemChec fallopian tube diagnostic
---------------------------------------------------------------------------

- FemChec cleared by FDA for controlled contrast delivery to check tubal status.
- FemChec is also used as confirmation test after FemBloc non-surgical permanent birth control.
- FemBloc is in late-stage FINALE pivotal trial, currently enrolling.
- FemChec uses natural contrast and ultrasound, avoiding x-ray dye and radiation exposure.
- CEO Kathy Lee-Sepsick says clearance strengthens women's health product suite.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036124040514/0001140361-24-040514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036124040514/ef20035640_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-040514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer